SU458966A3 - Способ получени таблеток - Google Patents

Способ получени таблеток

Info

Publication number
SU458966A3
SU458966A3 SU1247008A SU1247008A SU458966A3 SU 458966 A3 SU458966 A3 SU 458966A3 SU 1247008 A SU1247008 A SU 1247008A SU 1247008 A SU1247008 A SU 1247008A SU 458966 A3 SU458966 A3 SU 458966A3
Authority
SU
USSR - Soviet Union
Prior art keywords
core
producing tablets
tablets
pressure
ascorbic acid
Prior art date
Application number
SU1247008A
Other languages
English (en)
Russian (ru)
Inventor
Раймонд Делаби Пьер-Андрэ
Original Assignee
Ле Лаборатуар Досс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Досс filed Critical Ле Лаборатуар Досс
Application granted granted Critical
Publication of SU458966A3 publication Critical patent/SU458966A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
    • C04B41/45—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements
    • C04B41/50—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials
    • C04B41/5025—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials with ceramic materials
    • C04B41/5042—Zirconium oxides or zirconates; Hafnium oxides or hafnates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
SU1247008A 1967-06-15 1968-06-14 Способ получени таблеток SU458966A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR110534A FR1545612A (fr) 1967-06-15 1967-06-15 Procédé de fabrication de comprimés

Publications (1)

Publication Number Publication Date
SU458966A3 true SU458966A3 (ru) 1975-01-30

Family

ID=8633106

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1247008A SU458966A3 (ru) 1967-06-15 1968-06-14 Способ получени таблеток

Country Status (10)

Country Link
BE (1) BE716530A (it)
DE (1) DE1767765A1 (it)
ES (1) ES355054A1 (it)
FR (1) FR1545612A (it)
GB (1) GB1233055A (it)
IL (1) IL30165A (it)
IT (1) IT954035B (it)
LU (1) LU56264A1 (it)
NL (1) NL151902B (it)
SU (1) SU458966A3 (it)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
RU2531553C2 (ru) * 1994-07-08 2014-10-20 Астразенека Аб Таблетированная многоединичная лекарственная форма, способ её получения, упаковка и способ ингибирования секреции желудочной кислоты и/или лечения желудочно-кишечных воспалительных заболеваний
RU2538511C2 (ru) * 1994-07-08 2015-01-10 Астра Актиеболаг Таблетированная многоединичная лекарственная форма, способ ее получения, способ ингибирования секреции желудочной кислоты или лечения желудочно-кишечных заболеваний у млекопитающих и человека.

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2531553C2 (ru) * 1994-07-08 2014-10-20 Астразенека Аб Таблетированная многоединичная лекарственная форма, способ её получения, упаковка и способ ингибирования секреции желудочной кислоты и/или лечения желудочно-кишечных воспалительных заболеваний
RU2538511C2 (ru) * 1994-07-08 2015-01-10 Астра Актиеболаг Таблетированная многоединичная лекарственная форма, способ ее получения, способ ингибирования секреции желудочной кислоты или лечения желудочно-кишечных заболеваний у млекопитающих и человека.
US8022032B2 (en) 2004-11-19 2011-09-20 Smithkline Beecham Corporation Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US8383579B2 (en) 2004-11-19 2013-02-26 GlaxoSmithKline, LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies

Also Published As

Publication number Publication date
ES355054A1 (es) 1969-11-16
BE716530A (it) 1968-11-04
DE1767765A1 (de) 1972-03-30
LU56264A1 (it) 1968-09-23
NL151902B (nl) 1977-01-17
IL30165A0 (en) 1968-08-22
FR1545612A (fr) 1968-11-15
IL30165A (en) 1973-04-30
IT954035B (it) 1973-08-30
NL6808312A (it) 1968-12-16
GB1233055A (it) 1971-05-26

Similar Documents

Publication Publication Date Title
SU458966A3 (ru) Способ получени таблеток
KR840005661A (ko) 지속성 매트릭스 정제 조성물의 제조방법
GB1235787A (en) Sustained release pharmaceutical tablets
KR840006437A (ko) 항생제 경구 투여용 제형의 제조방법
ES264040A1 (es) Un metodo de fabricaciën de pastillas o granulos para administrar a rumiantes sustancias biolëgicamente activas
GB1272640A (en) Delayed or sustained release medicament dosages and a process for their manufacture
GB1002211A (en) Method of preparing sustained release pharmaceutical tablets
IL34148A0 (en) Esters of amino methyl-4-hydroxybenzyl alcohols,process for their preparation and compositions containing them
US3136695A (en) Anhydrous thixotropic gel sustained release therapeutic compositions and method of preparation
GB1513166A (en) Method of making granules
US2980589A (en) Process for producing anhydrous granulation of a medicinally active waterlabile powder
ES8205353A1 (es) Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico.
US3493659A (en) Compositions and process for the production thereof
IL35564A0 (en) Esters of substituted anthranilic acid,their preparation and pharmaceutical compositions containing them
ES441204A1 (es) Procedimiento para la produccion de formas de preparados ga-lenicos en forma de tabletas.
ES388917A1 (es) Procedimiento para la produccion de microgranulado solido, esferico, de libre fluencia.
GB1238811A (it)
ES397668A1 (es) Mejoras introducidas en un procedimiento para efectuar la interesterificacion de una mezcla de trigliceridos.
JPS51122383A (en) Semiconductor memory
JPS51123531A (en) Diode memory
ES419603A1 (es) Procedimiento para la produccion de tabletas mecanicamente estables y resistentes que contienen una o varias pirazolo- nas y eventualmente compuestos de cafeina.
ES372290A1 (es) Sistema para aportacion de agua a objetos que la requieren.
ES347878A2 (es) Procedimiento para la preparacion de composiciones tensio- activas.
ES381545A1 (es) Procedimiento para la obtencion de compuestos de moldeo termoplasticos.
ES361494A1 (es) Procedimiento para la preparacion de medicamentos con libe-racion prolongada de la sustancia activa.